Effect of heat and moisture exchangers on the prevention of ventilator-associated pneumonia in critically ill patients.

PubWeight™: 0.83‹?›

🔗 View Article (PMC 3854231)

Published in Braz J Med Biol Res on October 09, 2012

Authors

M Auxiliadora-Martins1, M G Menegueti, E A Nicolini, G C Alkmim-Teixeira, F Bellissimo-Rodrigues, O A Martins-Filho, A Basile-Filho

Author Affiliations

1: Divisão de Terapia Intensiva, Departamento de Cirurgia e Anatomia, Hospital das Clínicas, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brasil. mamartins@hcrp.usp.br

Articles cited by this

APACHE II: a severity of disease classification system. Crit Care Med (1985) 69.83

The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA (1995) 8.28

Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest (2002) 6.13

Oral decontamination with chlorhexidine reduces the incidence of ventilator-associated pneumonia. Am J Respir Crit Care Med (2006) 5.35

Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Crit Care Med (2005) 4.03

Guidelines for preventing health-care--associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep (2004) 3.84

Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center. Crit Care Med (2003) 2.59

The pathogenesis of ventilator-associated pneumonia: its relevance to developing effective strategies for prevention. Respir Care (2005) 2.41

International Conference for the Development of Consensus on the Diagnosis and Treatment of Ventilator-associated Pneumonia. Chest (2001) 2.13

Mortality rate attributable to ventilator-associated nosocomial pneumonia in an adult intensive care unit: a prospective case-control study. Crit Care Med (2001) 1.95

Heat and moisture exchangers and breathing system filters: their use in anaesthesia and intensive care. Part 2 - practical use, including problems, and their use with paediatric patients. Anaesthesia (2010) 1.83

Impact of humidification systems on ventilator-associated pneumonia: a randomized multicenter trial. Am J Respir Crit Care Med (2005) 1.76

Role of different routes of tracheal colonization in the development of pneumonia in patients receiving mechanical ventilation. Chest (1999) 1.70

Effectiveness of oral rinse with chlorhexidine in preventing nosocomial respiratory tract infections among intensive care unit patients. Infect Control Hosp Epidemiol (2009) 1.63

Impact of passive humidification on clinical outcomes of mechanically ventilated patients: a meta-analysis of randomized controlled trials. Crit Care Med (2007) 1.50

A prospective, randomized comparison of an in-line heat moisture exchange filter and heated wire humidifiers: rates of ventilator-associated early-onset (community-acquired) or late-onset (hospital-acquired) pneumonia and incidence of endotracheal tube occlusion. Chest (1997) 1.06

Clinical utility of hygroscopic heat and moisture exchangers in intensive care patients. Crit Care Med (1997) 1.04

Incidence rate and variable cost of nosocomial infections in different types of intensive care units. Infect Control Hosp Epidemiol (2009) 1.03

A randomized clinical trial comparing an extended-use hygroscopic condenser humidifier with heated-water humidification in mechanically ventilated patients. Chest (1998) 0.96

A randomized clinical trial to compare the effects of a heat and moisture exchanger with a heated humidifying system on the occurrence rate of ventilator-associated pneumonia. Am J Infect Control (2001) 0.96

Heat and moisture exchangers and vaporizing humidifiers in the intensive care unit. Chest (1990) 0.95

Diagnosis and differential diagnosis of ventilator-associated pneumonia. Clin Chest Med (1995) 0.95

Safety of combined heat and moisture exchanger filters in long-term mechanical ventilation. Chest (1997) 0.93

Efficacy of heat and moisture exchangers in preventing ventilator-associated pneumonia: meta-analysis of randomized controlled trials. Intensive Care Med (2004) 0.93

Comparison of hydrophobic heat and moisture exchangers with heated humidifier during prolonged mechanical ventilation. Intensive Care Med (1992) 0.93

Mechanical ventilation with heated humidifiers or heat and moisture exchangers: effects on patient colonization and incidence of nosocomial pneumonia. Am J Respir Crit Care Med (1995) 0.92

Heat and moisture exchangers and breathing system filters: their use in anaesthesia and intensive care. Part 1 - history, principles and efficiency. Anaesthesia (2010) 0.91

Safety, efficacy, and cost-effectiveness of mechanical ventilation with humidifying filters changed every 48 hours: a prospective, randomized study. Crit Care Med (2000) 0.88

Ventilator-associated pneumonia using a heated humidifier or a heat and moisture exchanger: a randomized controlled trial [ISRCTN88724583]. Crit Care (2006) 0.87

Randomized clinical trial of extended use of a hydrophobic condenser humidifier: 1 vs. 7 days. Crit Care Med (2002) 0.86

Double-heater-wire circuits and heat-and-moisture exchangers and the risk of ventilator-associated pneumonia. Crit Care Med (2006) 0.85

A change in humidification system can eliminate endotracheal tube occlusion. J Crit Care (2011) 0.85

Hypercapnia due to a heat and moisture exchanger. Intensive Care Med (2000) 0.81

Changing heat and moisture exchangers after 96 hours rather than after 24 hours: a clinical and microbiological evaluation. Crit Care Med (2000) 0.80

Norepinephrine therapy in septic shock. Crit Care Med (1988) 0.78

Articles by these authors

Evidence that development of severe cardiomyopathy in human Chagas' disease is due to a Th1-specific immune response. Infect Immun (2003) 1.81

Mixed inflammatory/regulatory cytokine profile marked by simultaneous raise of interferon-gamma and interleukin-10 and low frequency of tumour necrosis factor-alpha(+) monocytes are hallmarks of active human visceral Leishmaniasis due to Leishmania chagasi infection. Clin Exp Immunol (2006) 1.45

A combination of benznidazole and ketoconazole enhances efficacy of chemotherapy of experimental Chagas' disease. J Antimicrob Chemother (2000) 1.23

Activated T and B lymphocytes in peripheral blood of patients with Chagas' disease. Int Immunol (1994) 1.16

Chagasic patients lack CD28 expression on many of their circulating T lymphocytes. Scand J Immunol (1996) 1.14

Are increased frequency of macrophage-like and natural killer (NK) cells, together with high levels of NKT and CD4+CD25high T cells balancing activated CD8+ T cells, the key to control Chagas' disease morbidity? Clin Exp Immunol (2006) 1.08

Cytokines as determinants of resistance and pathology in human Schistosoma mansoni infection. Braz J Med Biol Res (1998) 1.05

Cytokine production associated with periportal fibrosis during chronic schistosomiasis mansoni in humans. Infect Immun (2006) 1.05

Activation/modulation of adaptive immunity emerges simultaneously after 17DD yellow fever first-time vaccination: is this the key to prevent severe adverse reactions following immunization? Clin Exp Immunol (2007) 1.05

Strategy to assess the overall cytokine profile of circulating leukocytes and its association with distinct clinical forms of human Chagas disease. Scand J Immunol (2008) 1.04

Chagasic patients with indeterminate clinical form of the disease have high frequencies of circulating CD3+CD16-CD56+ natural killer T cells and CD4+CD25High regulatory T lymphocytes. Scand J Immunol (2005) 1.03

Anti-Trypanosoma cruzi immunoglobulin G1 can be a useful tool for diagnosis and prognosis of human Chagas' disease. Clin Diagn Lab Immunol (2001) 1.02

Immune response in human visceral leishmaniasis: analysis of the correlation between innate immunity cytokine profile and disease outcome. Scand J Immunol (2005) 1.00

Relationship between canine visceral leishmaniosis and the Leishmania (Leishmania) chagasi burden in dermal inflammatory foci. J Comp Pathol (2006) 0.99

Phenotypic features of circulating leucocytes as immunological markers for clinical status and bone marrow parasite density in dogs naturally infected by Leishmania chagasi. Clin Exp Immunol (2006) 0.99

The role of the immune response on the development of severe clinical forms of human Chagas disease. Mem Inst Oswaldo Cruz (1999) 0.98

Human Schistosomiasis mansoni: IL-10 modulates the in vitro granuloma formation. Parasite Immunol (1998) 0.97

Acute-phase protein alpha-1-acid glycoprotein mediates neutrophil migration failure in sepsis by a nitric oxide-dependent mechanism. Proc Natl Acad Sci U S A (2007) 0.93

Humoral and cellular immune responses in dogs with inapparent natural Leishmania infantum infection. Vet J (2011) 0.92

Benznidazole treatment during early-indeterminate Chagas' disease shifted the cytokine expression by innate and adaptive immunity cells toward a type 1-modulated immune profile. Scand J Immunol (2006) 0.92

Phenotypic features of peripheral blood leucocytes during early stages of human infection with Trypanosoma cruzi. Scand J Immunol (2003) 0.91

Analysis of the effects of treatment of human Schistosoma mansoni infection on the immune response of patients from endemic areas. Acta Trop (2000) 0.91

Follow-up of experimental chronic Chagas' disease in dogs: use of polymerase chain reaction (PCR) compared with parasitological and serological methods. Acta Trop (2002) 0.90

HLA class II alleles and chronic hepatitis C virus infection. Scand J Immunol (2011) 0.89

Neutrophil function in severe sepsis. Endocr Metab Immune Disord Drug Targets (2006) 0.88

Clinical value of anti-live Leishmania (Viannia) braziliensis immunoglobulin G subclasses, detected by flow cytometry, for diagnosing active localized cutaneous leishmaniasis. Trop Med Int Health (2006) 0.87

Persistence of PCR-positive tissue in benznidazole-treated mice with negative blood parasitological and serological tests in dual infections with Trypanosoma cruzi stocks from different genotypes. J Antimicrob Chemother (2008) 0.87

Evaluation of the influence of tissue parasite density on hematological and phenotypic cellular parameters of circulating leukocytes and splenocytes during ongoing canine visceral leishmaniasis. Parasitol Res (2008) 0.87

In vitro activity of hypnophilin from Lentinus strigosus: a potential prototype for Chagas disease and leishmaniasis chemotherapy. Braz J Med Biol Res (2010) 0.86

IL-10 produced by CD4+ and CD8+ T cells emerge as a putative immunoregulatory mechanism to counterbalance the monocyte-derived TNF-alpha and guarantee asymptomatic clinical status during chronic HTLV-I infection. Clin Exp Immunol (2007) 0.85

Comparison of acute physiology and chronic health evaluation II death risk, Child-Pugh, Charlson, and model for end-stage liver disease indexes to predict early mortality after liver transplantation. Transplant Proc (2011) 0.85

Posttherapeutic cure criteria in Chagas' disease: conventional serology followed by supplementary serological, parasitological, and molecular tests. Clin Vaccine Immunol (2012) 0.85

Natural killer cell subpopulations in putative resistant individuals and patients with active Mycobacterium tuberculosis infection. Scand J Immunol (2008) 0.85

Phenotypic study of peripheral blood leucocytes in HTLV-I-infected individuals from Minas Gerais, Brazil. Scand J Immunol (2002) 0.85

Trypanosoma cruzi: immunoglobulin isotype profiles during the acute phase of canine experimental infection with metacyclic or blood trypomastigotes. Exp Parasitol (2008) 0.83

Impaired phagocytic capacity driven by downregulation of major phagocytosis-related cell surface molecules elicits an overall modulatory cytokine profile in neutrophils and monocytes from the indeterminate clinical form of Chagas disease. Immunobiology (2012) 0.82

Ageing and Toll-like receptor expression by innate immune cells in chronic human schistosomiasis. Clin Exp Immunol (2007) 0.82

Phenotypic study of peripheral blood lymphocytes and humoral immune response in Helicobacter pylori infection according to age. Scand J Immunol (2005) 0.81

A shift towards a T cell cytokine deficiency along with an anti-inflammatory/regulatory microenvironment may enable the synthesis of anti-FVIII inhibitors in haemophilia A patients. Clin Exp Immunol (2010) 0.80

Alcohol-induced gastritis prevents oral tolerance induction in mice. Clin Exp Immunol (2006) 0.80

Impact of dual infections on chemotherapeutic efficacy in BALB/c mice infected with major genotypes of Trypanosoma cruzi. Antimicrob Agents Chemother (2007) 0.80

Establishing phenotypic features associated with morbidity in human T-cell lymphotropic virus type 1 infection. Clin Diagn Lab Immunol (2004) 0.80

Flow cytometry analysis of the circulating haemocytes from Biomphalaria glabrata and Biomphalaria tenagophila following Schistosoma mansoni infection. Parasitology (2009) 0.80

Azithromycin and spiramycin induce anti-inflammatory response in human trophoblastic (BeWo) cells infected by Toxoplasma gondii but are able to control infection. Placenta (2011) 0.78

The role of IFN-gamma and IL-4 in gastric mucosa inflammation associated with Helicobacter heilmannii type 1 infection. Braz J Med Biol Res (2006) 0.78

The study of T-cell activation in peripheral blood and spleen of hepatosplenic patients suggests an exchange of cells between these two compartments in advanced human Schistosomiasis mansoni infection. Scand J Immunol (2002) 0.78

Meningoencephalitis caused by a zygomycete fungus (Basidiobolus) associated with septic shock in an immunocompetent patient: 1-year follow-up after treatment. Braz J Med Biol Res (2010) 0.78

Impact of MK886 on eosinophil counts and phenotypic features in toxocariasis. Scand J Immunol (2007) 0.77

Distinct pattern of immunophenotypic features of innate and adaptive immunity as a putative signature of clinical and laboratorial status of patients with localized cutaneous leishmaniasis. Scand J Immunol (2012) 0.77

Cholesterol addition protects membrane intactness during cryopreservation of stallion sperm. Anim Reprod Sci (2009) 0.77

Intracellular nitric oxide assessment in whole blood leukocytes by flow cytometry: optimization and applicability to monitor patients with chronic graft nephropathy. J Immunol Methods (2009) 0.77

Short-term administration of ethanol in mice deviates antigen presentation activity towards B cells. Scand J Immunol (2009) 0.77

Differences in peripheral blood lymphocyte phenotypes between Helicobacter pylori-positive children and adults with duodenal ulcer. Clin Microbiol Infect (2007) 0.77

Immunological/virological peripheral blood biomarkers and distinct patterns of sleeping quality in chronic hepatitis C patients. Scand J Immunol (2011) 0.77

Comparative phenotypic profile of subpopulations of peripheral blood leukocytes in European (Bos taurus taurus) and Zebu cattle (Bos taurus indicus). Genet Mol Res (2013) 0.77

Cytokine profile and FVIII inhibitors development in haemophilia A. Haemophilia (2013) 0.76

Differential apoptosis in BeWo cells after infection with highly (RH) or moderately (ME49) virulent strains of Toxoplasma gondii is related to the cytokine profile secreted, the death receptor Fas expression and phosphorylated ERK1/2 expression. Placenta (2013) 0.76

Trophoblast cells are able to regulate monocyte activity to control Toxoplasma gondii infection. Placenta (2013) 0.76

The long-term impaired macrophages functions are already observed early after high-dose ethanol administration. Scand J Immunol (2008) 0.76

Vancomycin-resistant enterococcus outbreak in a pediatric intensive care unit: report of successful interventions for control and prevention. Braz J Med Biol Res (2012) 0.75

Nutritional support: assessment of the critically ill patient. Nutrition (1992) 0.75

Cellular immune responses in Helicobacter heilmannii infection: evaluation of the role of the host and the bacterium. Dig Dis Sci (2002) 0.75

Expression of the chemokine receptor CXCR4 on lymphocytes of leprosy patients. Braz J Med Biol Res (2011) 0.75

Immune response of bovines stimulated by synthetic vaccine SBm7462 against Rhipicephalus (Boophilus) microplus. Vet Parasitol (2009) 0.75

13CO2 recovery fraction in expired air of septic patients under mechanical ventilation. Braz J Med Biol Res (2008) 0.75

Twenty-four-hour oral tracer studies with L-[1-13C]lysine at a low (15 mg.kg (-1).d (-1) and intermediate (29 mg.kg (-1).d(-1)) lysine intake in healthy adults. Am J Clin Nutr (2000) 0.75